Archives

by in
Entry Author Date Location
Sarepta Holds Its Breath as Feds Order Halt to Ebola Work 08/07/12 Seattle
Alnylam Stock Climbs on Positive Early Trial for Amyloidosis 07/16/12 Boston
Marina Biotech Runs Out of Cash, Axes 90% of Staff 06/01/12 Seattle
BioPharma Needs A Safe, Reliable Way To Repair Broken Genes 04/11/12 Seattle
Alnylam Cuts One-Third of Workforce, To Save Cash for RNAi Clinical Plans 01/19/12 Boston
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Alnylam Racing to Prove RNAi Works, For a Disease You’ve Never Heard Of 12/13/11 Boston
Marina Biotech Finds $15M From Investor to Keep Pursuing RNAi Drugs 10/17/11 Seattle
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News 10/07/11 Boston
Tweetchat on RNA Interference Upstages iPhone (Not Really, but It Was Still Fun) 10/05/11 National
Marina Biotech Ends Bothell Lease on Nasal Spray Building, Coughs up Shares to Landlord 10/04/11 Seattle
Join Us at 1 pm Eastern/10 am Pacific for RNAi “Tweetchat” with Alnylam’s John Maraganore 10/04/11 National
RXi Splits Up, Zeo Launches Mobile Sleep-Tracking App, Karuna Licenses Schizophrenia Compounds, & More Boston-Area Life Sciences News 09/30/11 Boston
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News 09/29/11 Seattle
Join Us for a Live ‘Tweetchat’ on the Future of RNAi, With Guest John Maraganore of Alnylam 09/28/11 National
Marina Biotech Shuffles Management Team, as RNAi Falls Out of Favor, Cash Runs Low 09/07/11 Seattle
AVI Starts Duchenne Trial 08/15/11 Seattle
Time to Cure Cancer or Stash Cash Under the Mattress? 08/15/11 National
Adventrx Shares Plummet, Pfizer Adds UC San Diego to its Network, New RNAi Center Opens, & More San Diego Life Sciences News 08/11/11 San Diego
Merck Shuts Down RNAi Research Center in SF, Cutting 50 Jobs 07/29/11 San Francisco
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News 07/29/11 Boston
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
Marina Biotech Adds $6.9M 05/17/11 Seattle
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn? 05/16/11 National
Alnylam Responds to Tekmira Suit 04/06/11 Boston
AVI Biopharma Adds $30M 04/01/11 Seattle
RXi Buys Apthera, Names New CEO 03/31/11 Boston
AVI Biopharma Adds Chief Scientist 03/28/11 Seattle
Who’s Going to Pay for Future Drug Development? (Part 1) 03/22/11 National
Page 2 of 7 « previous page · next page »